Finally, tumors of CRC patients classified as CMS4 showed high expressions of EMT genes and gene expression profiles that could be connected to an activation of TGF-β signaling, tumor cell–matrix interaction, angiogenesis, and metastasis formation, as well as inflammation (i.e., mesenchymal subtype). This evidence concerns the gene TGFB1 and colorectal carcinoma.